Harman-d3 - HY-W700834
Catalog #
HY-W700834
Harman-d3 is deuterium labeled Harmane. Harmane is a benzodiazepine receptor inhibitor (IC50=7 μM), with IC50 values for mACh, Opioid Receptor, MAO-A/B, and α2-adrenergic receptor of 24 μM, 2.8 μM, 0.5 μM, 5 μM, and 18 μM, respectively. Harmane also inhibits haloperidol and serotonin, with IC50 values of 163 μM and 101 μM, respectively. Harmane inhibits the I1 imidazoline receptor (IC50=30 nM) to reduce blood pressure and has antidepressant, anti-anxiety, anticonvulsant, and analgesic effects. Harmane inhibits dopamine biosynthesis by decreasing tyrosine hydroxylase (TH) activity and enhancing L-DOPA-induced cytotoxicity in PC12 cells. Additionally, Harmane can increase the mutagenic effect induced by 2-acetylaminofluorene (AAF)[1][2][3][4][5][6].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-W700834/Harman-d3-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | Get quote |
| Shipping | Room temperature |
| Application | COVID-19-immunoregulation |
| CAS | 1216708-84-7 |
| MWT | 185.24 |
| Clinical Information | No Development Reported |
| Target | Isotope-Labeled Compounds |
| Application: | COVID-19-immunoregulation |
|---|